Morbidity and mortality in the surgery arm of EORTC 08941 trial

European Respiratory Journal

Volumn 26, Issue 2, 2005, Pages 192-197

  Van Schil, Paul ^a,b   Van Meerbeeck, J ^a   Kramer, G ^a   Splinter, T ^a   Legrand, C ^a   Giaccone, G ^a   Manegold, C ^a   van Zandwijk, N ^a  

^a EORTC DATA CENTER   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Chemotherapy; Lung cancer; Morbidity; Mortality; Neoadjuvant therapy; Surgery

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; GEMCITABINE; MITOMYCIN; PACLITAXEL; PLATINUM DERIVATIVE; VINDESINE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; ATELECTASIS; BRONCHITIS; BRONCHOPLEURAL FISTULA; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DYSPNEA; EMPYEMA; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HEMATOMA; HEMATOTHORAX; HISTOLOGY; HUMAN; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MORBIDITY; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REOPERATION; RESPIRATORY FAILURE; RESPIRATORY TRACT DISEASE; SURGICAL TECHNIQUE; THROMBOEMBOLISM; WOUND INFECTION;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; EUROPE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PNEUMONECTOMY; RADIOTHERAPY, ADJUVANT;

EID: 23144455515     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.05.00127204     Document Type: Article

References (13)

1. Keller SM, Vangel MG, Wagner H, et al. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease. J Thorac Cardiovasc Surg 2004; 128: 130-137.
2. Splinter T, Van Schil P, Kramer G, et al. Randomized trial of surgery versus radiotherapy in patients with stage IIIA(N2) non-small cell lung cancer after a response to induction chemotherapy. EORTC 08941. Clin Lung Cancer 2000; 2: 69-72.
3. Albain KS, Scott CB, Rusch VW, et al. Phase III study of concurrent chemotherapy and full course radiotherapy (CT/RT) versus CT/RT induction followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC): first outcome analysis of North American Intergroup trial 0139 (RTOG 93-09). Lung Cancer 2003; 41: Suppl. 2, S4.
4. Fowler WC, Langer CJ, Curran WJ Jr, Keller SM. Postoperative complications after combined neoadjuvant treatment of lung cancer. Ann Thorac Surg 1993; 55: 986-989.
5. Martin J, Ginsberg RJ, Abolhoda A, et al. Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy. Ann Thorac Surg 2001; 72: 1149-1154.
6. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111: 1710-1717.
7. Van Meerbeeck J, Kramer G, Van Schil P, et al. Induction chemotherapy in stage IIIA-N2 non-small cell lung cancer (NSCLC): an analysis of different regimens used in EORTC 08941. Lung Cancer 2003; 41: Suppl. 2, S79-S80.
8. Liptay MJ, Fry WA. Complications from induction regimens for thoracic malignancies. Perioperative considerations. Chest Surg Clin North Am 1999; 9: 79-95.
9. Rusch VW, Benfield JR. Neoadjuvant therapy for lung cancer: a note of caution. Ann Thorac Surg 1993; 55: 820-821.
10. Abolhoda A, Martin J, Ginsberg RJ, et al. Morbidity and mortality for pulmonary resections in lung cancer after induction treatment. Lung Cancer 2000; 29: Suppl. 1, 89-90.
11. Siegenthaler MP, Pisters KM, Merriman KW, et al. Preoperative chemotherapy for lung cancer does not increase surgical morbidity. Ann Thorac Surg 2001; 71: 1105-1112.
12. Stamatis G, Djuric D, Eberhardt W, et al. Postoperative morbidity and mortality after induction chemoradiotherapy for locally advanced lung cancer: an analysis of 350 operated patients. Eur J Cardiothorac Surg 2002; 22: 292-297.
13. Patel AN, Luketich JD, Fernando HC, Christie NA, Ferson P, Landreneau RJ. Morbidity of pneumonectomy in the age of neoadjuvant therapy for lung cancer. J Clin Oncol 2004; 22: Suppl. 14, 660s (abstract 7176).